Quick-Med Technologies has submitted a grant application for Nimbus, an antimicrobial technology developed for wound care, medical device and adhesive applications, and received the award based on its responsiveness to the QTDP threshold criteria.

The grant has been authorized by the US Department of the Treasury for payment in November 2010.

Med Technologies CEO Ladd Greeno said that Nimbus offers highly effective, non-toxic, long-lasting, non-leaching and affordable antimicrobial protection can make an important contribution to eliminate healthcare associated infections and reducing healthcare costs in wound dressings.

The QTDP grant program provides support for projects that are determined by the US Department of Health and Human Services (HHS) to result in a new therapy, reduce health care costs, or advance the goal of curing cancer.